Safety of anti-immunoglobulin E therapy with omalizumab in allergic patients at risk of geohelminth infection

Article

Abstract: Background: Although the role of immunoglobulin E (IgE) in immunity against helminth parasites is un

Palabras claves:

Allergic rhinitis, Asthma, Geohelminth infections, immunoglobulin E, Monoclonal antibody, Omalizumab

Autores:

Ayre G., Cruz A.C., Fox H., Lima F., Martin C., Philip John Cooper, Sarinho E.

Fuentes:

scopus